After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Over the last six months, ANGLE has overcome technical issues to successfully use Illumina assays, coupled with their next generation sequencing (NGS) platform, to provide a complete solution for the ...

So-called buddy lasing, where one aircraft designates the target for another, could also be useful in this case, especially given the speed differential between typical Houthi drones and F-16s. One ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

First Quantum Minerals (TSX: FM) has cut its copper guidance by 3.5% at the midpoint, citing Zambian mine sequencing, while politics has kept Cobre Panama idle. The Toronto-headquartered company ...

It’s been a busy week for Illumina at the JP Morgan 2025 Healthcare conference, with the company revealing partnerships and investment participation. Finally turning attention to itself, the ...

"Cost is a direct relationship to technology advances," Dr. Steven Barnard—chief technology officer of Illumina, the market leader in DNA sequencing machines—told Newsweek. The cost of the ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech ...